MedPath

NAFDAC Launches Electronic Clinical Trial Application Platform

NAFDAC has introduced the NAFDAC Electronic Clinical Trial Application Platform (NAFDAC-eCTAP), in collaboration with NUVOTEQ and supported by the Gates Foundation, to streamline the submission process for clinical trial applications, amendments, and reports.

NAFDAC has launched the NAFDAC Electronic Clinical Trial Application Platform (NAFDAC-eCTAP) in partnership with NUVOTEQ and support from the Gates Foundation. This online platform is designed to provide a seamless and transparent system for submitting clinical trial applications, amendments, and progress/final reports. It also facilitates the importation of investigational medicinal products (IMP) for clinical trials. The NAFDAC-eCTAP aims to reduce turnaround times, mitigate challenges of paper-based submissions, and improve applicant’s ability to track progress. It is the first electronic application platform of its kind in Africa and can be accessed on the NAFDAC website.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

National Taiwan University Hospital and AbbVie Biopharma Enhance Digital Strategies for Clinical Trials

National Taiwan University Hospital (NTUH) and AbbVie Biopharmaceuticals GmbH Taiwan Branch have signed a cooperation agreement to strengthen digital strategies for clinical trials, aiming to accelerate trial approvals and improve quality. This collaboration builds on a decade-long partnership that has seen significant milestones in clinical trial research.

Takeda Partners with Koneksa Health to Digitize Clinical Trials Using Wearable Sensor Data

Takeda collaborates with Koneksa Health to integrate real-world data into early-stage clinical trials, aiming to enhance drug development.
Koneksa's platform will collect continuous vital signs, activity levels, and sleep metrics via wearables and biosensors for remote monitoring.

Fox Chase Cancer Center Streamlines Clinical Trial Activation, Reducing Time by 182 Days

Fox Chase Cancer Center's Study Activation Unit (SAU) has significantly reduced the median time to new study activation by 182 days, surpassing their initial goal.
The SAU implemented a centralized, desegregated model to streamline bureaucratic processes and improve interdepartmental communication for clinical trial initiation.

Anocca Submits Clinical Trial Application to EMA for ANOC-001 in Advanced Pancreatic Cancer

Anocca has submitted a Clinical Trial Application (CTA) to the EMA for its VIDAR-1 Phase I/II trial.
The VIDAR-1 trial will evaluate ANOC-001, a TCR-T cell therapy, in patients with advanced pancreatic cancer.

NWEH Pilot Aims to Accelerate UK Clinical Trial Recruitment Using CPRD Data

NorthWest EHealth (NWEH) is piloting a new model to expedite clinical trial participant recruitment using the Clinical Practice Research Datalink (CPRD).
The initiative combines NWEH's FARSITE platform with CPRD's 18-million anonymized patient records for efficient feasibility studies.

NorthWest EHealth Pilots AI-Driven Platform to Accelerate UK Clinical Trial Recruitment

NorthWest EHealth (NWEH) is piloting a new model to expedite clinical trial participant recruitment in the UK using its FARSITE platform and CPRD data.
The initiative combines NWEH's FARSITE platform with CPRD's 18-million anonymized patient records for rapid feasibility studies and find-and-refer services.

Appili Therapeutics Gains FDA Alignment on ATI-1801 Development for Leishmaniasis

Appili Therapeutics has received positive feedback from the FDA regarding its development strategy for ATI-1801, a topical antiparasitic product.
ATI-1801 is being developed for the treatment of leishmaniasis, a disfiguring parasitic disease with significant unmet medical needs.

Medidata Launches Bundled Solutions to Accelerate Oncology and Vaccine Trials

Medidata has launched bundled solutions for oncology and vaccine trials, integrating technologies to streamline study management and decision-making.
The new offerings, Medidata Oncology Solutions and Medidata Vaccine Solutions, aim to improve treatment efficacy and safety assessments.

DiMe's DATAcc Receives FDA Grant to Advance Sensor-Based Digital Health Technologies in Clinical Trials

The Digital Health Measurement Collaborative Community (DATAcc) by DiMe has been awarded an FDA grant to create a comprehensive guide for using sensor-based digital health technologies (sDHTs) in clinical trials.
The guide will address market challenges by clarifying how and why to include digital endpoints in clinical trials, aiming to reduce timelines and improve ROI.

ClinicalTrials.EU Platform Launches to Streamline Patient Recruitment for European Clinical Trials

ClinicalTrials.EU, a patient-centric platform, has officially launched across Europe to address challenges in clinical trial patient recruitment.
The platform aims to democratize patient access to clinical trials by providing comprehensive information in seven European languages.

Reference News

[1]
Application for Clinical Trials
nafdac.gov.ng · Jan 11, 2024

NAFDAC launched NAFDAC-eCTAP, an online platform for clinical trial applications, amendments, and reports, in partnershi...

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy